Q1 Earnings Forecast for Zymeworks Issued By Lifesci Capital
Zymeworks Inc. (NYSE:ZYME – Free Report) – Analysts at Lifesci Capital issued their Q1 2025 EPS estimates for Zymeworks in a research note issued to investors on Tuesday, March 11th. Lifesci Capital analyst C. Zhu anticipates that the company will post earnings of ($0.50) per share for the quarter. Lifesci Capital currently has a “Outperform” […]
